Brief: Biotec Pharmacon Says Decided To Stop Further Development Of Woulgan And Search For A New Product Owner
02/12/2019 16:36
Dec 2 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* BIOTEC PHARMACON CHANGES ITS STRATEGIC DIRECTION AND
INVITES
SHAREHOLDERS TO AN UPDATE PRESENTATION
* BIOTEC PHARMACON ASA - COMPANY HAS DECIDED TO STOP FURTHER
DEVELOPMENT OF WOULGAN® AND SEARCH FOR A NEW PRODUCT OWNER
* BIOTEC PHARMACON - CO TO UNDERGO A STRUCTURAL
REORGANISATION
ENSURING APPROPRIATE LEVEL OF RESOURCES ARE ALLOCATED TO
RESPECTIVE BUSINESSES
* BIOTEC PHARMACON ASA - UNNECESSARY COSTS WILL BE
ELIMINATED WITH
INTENTION OF DRIVING GROUP TO PROFITABILITY DURING 2020
* BIOTEC PHARMACON ASA - ANIMAL AND CONSUMER HEALTH
BUSINESSES ARE
A PROFITABLE PART OF COMPANY AND WILL BE INTEGRATED UNDER
ARCTICZYMES
Source text for Eikon: ID:nWkr1CfxT2
Further company coverage: BIOTEC.OL
((Reuters.Briefs@thomsonreuters.com;))